
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SMPDL3B CRISPR/Cas9 KO Plasmid (m) | sc-430315 | 20 µg | $397.00 |
Smpdl3b encodes sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B), a membrane-associated phosphodiesterase implicated in regulating sphingolipid and phospholipid metabolism at the cell surface. SMPDL3B has been linked to modulation of Toll-like receptor signaling, macrophage activation states, and homeostatic control of inflammatory responses through effects on membrane lipid composition and receptor organization. In mouse immune and renal biology, altered SMPDL3B activity has been associated with changes in innate immune responsiveness and podocyte function, connecting lipid remodeling to tissue injury and inflammation. As a result, Smpdl3b is frequently studied in pathways intersecting lipid signaling, endolysosomal trafficking, and immune-cell phenotypes relevant to inflammatory and metabolic disease models.
SMPDL3B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Smpdl3b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Smpdl3b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Smpdl3b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SMPDL3B protein expression.
This CRISPR knockout system enables efficient generation of Smpdl3b-deficient cell models for investigation of SMPDL3B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.